Surrogate endpoints, part 1 from definition to meta-analytic framework /

Volledige tekst
Series

Surrogate endpoints, part 2 further developments /

Volledige tekst
Series

Phase II clinical trials traditional approaches /

Volledige tekst
Series

Implementation of adaptive methods in early phase clinical trials

Volledige tekst
Series

Metabolomics importance of experimental design to data acquisition, part 1 of 2 /

Volledige tekst
Series

Ecological considerations for gene drive systems

Volledige tekst
Series

Guidance for responsible testing and implementation of gene-drive systems

Volledige tekst
Series

Adaptation in likelihood trials

Volledige tekst
Series

Data fusion examples in fusing metabolomics and transcriptomics data /

Volledige tekst
Series

Bridging our mandates evidence-based practice (EBP) and patient-centered care (PCC), part 1 of 2 /

Volledige tekst
Series

Clinical research and care in the era of "N-of-1" precision cancer medicine

Volledige tekst
Series

Bridging our mandates evidence-based practice (EBP) and patient-centered care (PCC), part 2 of 2/

Volledige tekst
Series

Comparing transcriptomes of distant organisms the comparative ENCODE resource, part 1 of 2 /

Volledige tekst
Series

Comparing transcriptomes of distant organisms models of gene expression, part 2 of 2 /

Volledige tekst
Series

Assessing and managing thermoregulatory responses to heat loss a research journey /

Volledige tekst
Series

Case studies of adaptive early phase trials

Volledige tekst
Series

Bayesian adaptive designs for clinical trials

Volledige tekst
Series

Seamless phase II/III trials

Volledige tekst
Series

Adaptive designs for phase I trials part 2 of 2 /

Volledige tekst
Series (Risk of bias in randomized clinical trials)
Series (Adaptive clinical trial design)

Biomarkers and surrogate endpoints in randomized clinical trials

Volledige tekst
Series